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When we think of threats to our way of life, we tend to think of ISIL (‘Islamic State of Iraq 
and the Levant’) and Al-Qaeda, of lone gunmen on Tunisian beaches or Norwegian islands, 
or of bombers on the London Underground, not Escherichia coli, Klebsiella 
pneumoniae or Acinetobacter baumannii. Yet it is the increasing antibiotic-resistance of 
micro-organisms such as these that will kill an estimated 10 million people annually 
worldwide by 2050 ‒ more than currently die from cancer and road traffic accidents 
combined ‒ and which will cost the global economy US$100 trillion. 1 The number lost to 
terrorism – in 2013 approximately 18,000, which is estimated to have doubled due to the ISIL 
threat in 2014 – pales into insignificance compared with the threat of antimicrobial 
resistance.2 
 
It should not, therefore, be a surprise that research into the challenge from antimicrobial 
resistance has been on the agenda of the Royal United Services Institute for Defence and 
Security Studies ‒ better known as a defence and security think tank ‒ since 2012; nor that, 
when the latest version of the UK's National Risk Register (NRR) was published in March 
2015, antimicrobial resistance received a special mention.3 Although, after long consultations 
within Government, it was not added to the NRR matrix in its own right (as volcanic 
eruptions and wildfires tend to be when they occur), it was included within the same 
framework as terrorist attacks and devastating earthquakes. 
 
There are several reasons for this inclusion. As infections become harder to treat, the more 
attractive they may become as a weapon of bioterror. Furthermore, A. baumannii and other 
multidrug-resistant bacteria are already causing challenges to UK military operations. 4 And 
at a more fundamental level, one of the three criteria defining civil emergency in the NRR is 
‘an event or situation which threatens serious damage to human welfare’. The National 
Security Strategy talks of ‘ensuring a secure and resilient UK – protecting our people, 
economy, infrastructure, territory and way of life from all major risks that can affect us 
directly’.5 Antimicrobial resistance undoubtedly fits these criteria as it threatens to undermine 
the healthy lives we have taken for granted since Alexander Fleming's discovery of penicillin 
in 1928. Thanks in large part to antibiotics, we have been freed from fear that we (or our 
children) will die during childbirth, from childhood infections in infancy, or from minor cuts 
and scrapes becoming infected throughout life; and so we can survive long enough to need 
the cancer treatments and hip replacements AMR also threatens. The rapid increase in life 
expectancy seen in the mid-20th century could be reversed if we do not act swiftly and 
collectively across disciplines and sectors (health and security) as well as across geographic 
and organizational borders. 
 
An estimated 700,000 individuals die worldwide each year from antimicrobial resistance, 
50,000 of those in the UK and USA.1 The ‘reasonable worst case scenario’ premise on which 
the National Risk Assessment (which leads to the NRR) is conducted predicts that a 
widespread outbreak of a drug-resistant pathogen could result in up to 200,000 people being 
affected by a bacterial blood infection that could not be treated effectively with existing 
drugs, with a potential death toll of around 80,000. 
 
Global consumption of antibiotics in human medicine rose by 40% in the first decade of the 
21st century despite the challenge being well understood by that time, with the BRIC nations 
(Brazil, Russia, India, China) responsible for three-quarters of this growth.6 As health 
systems and health provisions increase in less developed nations, particularly across Africa, 
we need to understand how we can prevent their consumption from growing at similar rates. 
 
The World Health Organization is taking the lead to agree a global action plan to tackle 
antimicrobial resistance among 194 countries. Such initiatives need the full co-operation of 
all parties, but this does not and should not prevent us from simultaneously acting at the 
grassroots level, as well as at the international strategic level, if we are to avoid a ‘tragedy of 
the commons’ in which every potential actor waits for the others to take first action. Good 
antimicrobial stewardship begins with general practitioners taking the time to explain why 
antibiotics will make no difference to a patient's runny nose, and with the patient being 
willing to listen. It begins with junior doctors having the confidence to think twice in 
situations where more experienced colleagues may make a different prescribing decision. 
Without a concerted attack from the ground troops, as well as strategic planning, the war will 
never be won. 
 
As the UK's Review on Antimicrobial Resistance points out, it would be unforgiveable if the 
great progress made in combating infectious disease were threatened by lack of common 
sense – not least because Fleming himself saw the dangers coming and made full reference to 
them in his Nobel Prize acceptance speech of 1945. We cannot claim that we did not foresee 
the danger, or that it was an ‘unknown unknown’. 
Is antimicrobial resistance a national security risk? Yes, if it has the ability to kill UK citizens 
in their thousands, to fundamentally change the way we expect to live our lives, to reduce our 
personal longevity, and to undermine the health provision we currently expect. No terrorist 
organization would be allowed to get away with so much. 
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